Cargando…
IMPROVED SURVIVAL OUTCOME IN PATIENTS WITH SARS-COV-2 (COVID-19) ARDS WITH TOCILIZUMAB ADMINISTRATION
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548660/ http://dx.doi.org/10.1016/j.chest.2020.08.654 |
| _version_ | 1783592665604947968 |
|---|---|
| author | Wadud, Nafisa Ahmed, Naim Shergill, Mannu Khan, Maida Krishna, Murali Gilani, Aamir El Zarif, Samer Galaydick, Jodi Linga, Karthika Kooragayalu, Shravan Galea, Julia Stuczynski, Lauren Osundele, Maria |
| author_facet | Wadud, Nafisa Ahmed, Naim Shergill, Mannu Khan, Maida Krishna, Murali Gilani, Aamir El Zarif, Samer Galaydick, Jodi Linga, Karthika Kooragayalu, Shravan Galea, Julia Stuczynski, Lauren Osundele, Maria |
| author_sort | Wadud, Nafisa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7548660 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | American College of Chest Physicians. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75486602020-10-13 IMPROVED SURVIVAL OUTCOME IN PATIENTS WITH SARS-COV-2 (COVID-19) ARDS WITH TOCILIZUMAB ADMINISTRATION Wadud, Nafisa Ahmed, Naim Shergill, Mannu Khan, Maida Krishna, Murali Gilani, Aamir El Zarif, Samer Galaydick, Jodi Linga, Karthika Kooragayalu, Shravan Galea, Julia Stuczynski, Lauren Osundele, Maria Chest Critical Care American College of Chest Physicians. Published by Elsevier Inc. 2020-10 2020-10-12 /pmc/articles/PMC7548660/ http://dx.doi.org/10.1016/j.chest.2020.08.654 Text en Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Critical Care Wadud, Nafisa Ahmed, Naim Shergill, Mannu Khan, Maida Krishna, Murali Gilani, Aamir El Zarif, Samer Galaydick, Jodi Linga, Karthika Kooragayalu, Shravan Galea, Julia Stuczynski, Lauren Osundele, Maria IMPROVED SURVIVAL OUTCOME IN PATIENTS WITH SARS-COV-2 (COVID-19) ARDS WITH TOCILIZUMAB ADMINISTRATION |
| title | IMPROVED SURVIVAL OUTCOME IN PATIENTS WITH SARS-COV-2 (COVID-19) ARDS WITH TOCILIZUMAB ADMINISTRATION |
| title_full | IMPROVED SURVIVAL OUTCOME IN PATIENTS WITH SARS-COV-2 (COVID-19) ARDS WITH TOCILIZUMAB ADMINISTRATION |
| title_fullStr | IMPROVED SURVIVAL OUTCOME IN PATIENTS WITH SARS-COV-2 (COVID-19) ARDS WITH TOCILIZUMAB ADMINISTRATION |
| title_full_unstemmed | IMPROVED SURVIVAL OUTCOME IN PATIENTS WITH SARS-COV-2 (COVID-19) ARDS WITH TOCILIZUMAB ADMINISTRATION |
| title_short | IMPROVED SURVIVAL OUTCOME IN PATIENTS WITH SARS-COV-2 (COVID-19) ARDS WITH TOCILIZUMAB ADMINISTRATION |
| title_sort | improved survival outcome in patients with sars-cov-2 (covid-19) ards with tocilizumab administration |
| topic | Critical Care |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548660/ http://dx.doi.org/10.1016/j.chest.2020.08.654 |
| work_keys_str_mv | AT wadudnafisa improvedsurvivaloutcomeinpatientswithsarscov2covid19ardswithtocilizumabadministration AT ahmednaim improvedsurvivaloutcomeinpatientswithsarscov2covid19ardswithtocilizumabadministration AT shergillmannu improvedsurvivaloutcomeinpatientswithsarscov2covid19ardswithtocilizumabadministration AT khanmaida improvedsurvivaloutcomeinpatientswithsarscov2covid19ardswithtocilizumabadministration AT krishnamurali improvedsurvivaloutcomeinpatientswithsarscov2covid19ardswithtocilizumabadministration AT gilaniaamir improvedsurvivaloutcomeinpatientswithsarscov2covid19ardswithtocilizumabadministration AT elzarifsamer improvedsurvivaloutcomeinpatientswithsarscov2covid19ardswithtocilizumabadministration AT galaydickjodi improvedsurvivaloutcomeinpatientswithsarscov2covid19ardswithtocilizumabadministration AT lingakarthika improvedsurvivaloutcomeinpatientswithsarscov2covid19ardswithtocilizumabadministration AT kooragayalushravan improvedsurvivaloutcomeinpatientswithsarscov2covid19ardswithtocilizumabadministration AT galeajulia improvedsurvivaloutcomeinpatientswithsarscov2covid19ardswithtocilizumabadministration AT stuczynskilauren improvedsurvivaloutcomeinpatientswithsarscov2covid19ardswithtocilizumabadministration AT osundelemaria improvedsurvivaloutcomeinpatientswithsarscov2covid19ardswithtocilizumabadministration |